American Picture House Corp
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2024-03-31; filed 2024-05-14.
0001493152-24-019186
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSCurrent report: 10-Q
Period ended 2024-06-30; filed 2024-08-13.
0001493152-24-031503
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 43 previous paragraphs and 68 current paragraphs.
31 unchanged; 10 reworded; 20 added; 2 removed; 0 previous and 7 current paragraphs rearranged.
Tables are not compared: 3 previous and 4 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (20)
Current report
The Company did not have any revenues during the quarters ended June 30, 2024 and 2023.
Current report
General and administrative expenses for the three months ended June 30, 2024 were approximately $380,000 compared to approximately $395,000 for the three months ended June 30, 2023, a decrease of approximately $15,000.
Current report
Research and Development Expenses
Current report
Research and development expenses for the three months ended June 30, 2024 were approximately $700 compared to $0 for the six months ended June 30, 2023.
Current report
During the three months ended June 30, 2024, net cash provided by financing activities was approximately $310,000 including $154,000 of proceeds from the sale of Common Stock and $1,570,000 of net working capital financing under a master loan agreement from a related party.
Current report
Six months ended June 30, 2024 Compared to six months ended June 30, 2023
Current report
Revenues and Cost of Revenues
Current report
General and Administrative Expenses
Current report
Research and Development Expenses
Current report
Research and development expenses for the six months ended June 30, 2024 were approximately $700 compared to $0 for the six months ended June 30, 2023.
Current report
Sales and Marketing Expenses
Current report
Other Income (Expense)
Current report
Liquidity and Capital Resources
Current report
Operating Activities
Current report
During the Six months ended June 30, 2023, operating activities consumed approximately $318,000 of cash, primarily resulting from our net loss, net of non-cash charges, of approximately $229,000.
Current report
Investing Activities
Current report
During the six months ended June 30, 2024 and 2023, investing activities consumed approximately $30,000 and $10,000 of cash. The 2024 period included $22,000 of website development costs and $8,000 of produced and licensed film production costs. Costs during the 2023 period included approximately $10,000 of produced and licensed film production costs.
Current report
Financing Activities
Current report
During the six months ended June 30, 2024, net cash provided by financing activities was approximately $576,000 including $415,000 of proceeds from the sale of Common Stock and $407,000 of net working capital financing under a master loan agreement from a related party and a commercial line of credit.
Current report
During the six months ended June 30, 2023, net cash provided by financing activities was approximately $562,000 including $460,000 of proceeds from the sale of Common Stock and $103,000 of net working capital financing under a master loan agreement from a related party and a commercial line of credit.
Removed paragraphs (2)
Previous report
During the three months ended March 31, 2023, operating activities consumed approximately $130,000 of cash, primarily resulting from $52,000 operating loss and payment of approximately $42,000 in accounts payable and accrued expenses.
Previous report
During the three months ended March 31, 2024, net cash provided by financing activities was approximately $265,000 including $15,000 of proceeds from the sale of Common Stock and $250,000 of working capital financing under a master loan agreement from a related party.
Reworded paragraphs (10)
Previous wording
Sales and marketing expenses for the three months ended March 31, 2024 were approximately $14,000 compared to $0 for the three months ended March 31, 2023. Sales and marketing expenses relate to our engagement of a part-time marketing consultant during the quarter and related expenses.
Current wording
Sales and marketing expenses for the three months ended June 30, 2024 were approximately $11,000 compared to $0 for the three months ended June 30, 2023. Sales and marketing expenses relate to our engagement of a part-time marketing consultant during the quarter and related expenses.
Previous wording
Interest Expense. Interest expense for the three months ended March 31, 2024 and 2023 was approximately $3,200 and $1,900, respectively, and was primarily related to ourEconomic Injury Disaster Loan (“EIDL”) and working capital loans.
Current wording
Interest Expense. Interest expense for the three months ended June 30, 2024 and 2023 was approximately $12,800 and $2,000, respectively, and was primarily related to ourEconomic Injury Disaster Loan (“EIDL”), commercial line of credit and related party working capital loans.
Previous wording
During the quarter ended March 31, 2024, the Company sold 75,000 shares of Common Stock at $0.20 per share to new investors resulting in total proceeds of approximately $15,000.
Current wording
During the quarter ended June 30, 2024, the Company sold 616,000 shares of Common Stock at $0.25 per share resulting in total proceeds of approximately $154,000. During the quarter ended June 30, 2023, the Company sold 3,333,333 shares of Common Stock at $0.15 per share resulting in total proceeds of approximately $500,000.
Previous wording
We had an accumulated deficit of approximately $6.5 million, incurred a net loss of approximately $1.5 million, and had cash outflows from operations of approximately $436,000 as of and for the three months ended March 31, 2024. Further, we expect to continue to incur significant costs in the pursuit of our business plans. We cannot assure you that our plans to raise capital or to complete our film development and production activities will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.
Current wording
We had an accumulated deficit of approximately $6.9 million, incurred a net loss of approximately $405,000, and had cash outflows from operations of approximately $3066,000 as of and for the three months ended June 30, 2024. Further, we expect to continue to incur significant costs in the pursuit of our business plans. We cannot assure you that our plans to raise capital or to complete our film development and production activities will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.
Previous wording
Since our inception, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we develop and produce feature films. To date, we have funded our operations with proceeds from sales of Common Stock and borrowings from related parties under promissory notes. As of March 31, 2024, we had cash and cash equivalents of approximately $25,000.
Current wording
Since our inception, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we develop and produce feature films. To date, we have funded our operations with proceeds from sales of Common Stock and borrowings from related parties under promissory notes. As of June 30, 2024, we had cash and cash equivalents of approximately $8,000.
Previous wording
During the three months ended March 31, 2024 and 2023, investing activities included approximately $5,000 and $10,000 of produced and licensed film production costs. Additionally, during the quarter ended March 31, 2024, the Company invested approximately $3,000 in capitalized software.
Current wording
During the three months ended June 30, 2024 and 2023, investing activities consumed approximately $22,000 and $0 of cash. During the quarter ended June 30, 2024, the Company invested approximately $19,000 in capitalized website development costs.
Previous wording
During the three months ended March 31, 2023, net cash provided by financing activities was $125,000 comprised of working capital financing under a master loan agreement from a related party.
Current wording
During the three months ended June 30, 2023, net cash provided by financing activities was $125,000 comprised of working capital financing under a master loan agreement from a related party and a new commercial line of credit.
Previous wording
During the three months ended March 31, 2024 and 2023, the Company had revenues of approximately $23,000 and $169,000, respectively. During the quarter ended March 31, 2024, the Company reported revenues of $23,003 from theBUFFALOED CAMA. Revenues during the 2023 period were derived from contracts with customers for consulting services.
Current wording
During the six months ended June 30, 2024 and 2023, the Company had revenues of approximately $23,000 and $169,000, respectively. The 2024 revenues were from the Buffaloed CAMA. Revenues during the 2023 period, were from contracts with customers for consulting services.
Previous wording
General and administrative expenses for the three months ended March 31, 2024 were approximately $1,502,000 compared to approximately $184,000 for the three months ended March 31, 2023, an increase of approximately $1.3 million. The increase was primarily attributable to the Company recording $1,258,160 of stock option compensation expense in the quarter ended March 31, 2024. As a public company, we expect general and administrative costs to continue to increase in future periods.
Current wording
General and administrative expenses for the six months ended June 30, 2024 were approximately $1,882,000 compared to approximately $579,000 for the six months ended June 30, 2023, an increase of approximately $1.3M. The increase was primarily attributable to the Company recording approximately $1,258,000 of stock option expense and a $186,000 increase in professional fees in the first half of 2024. The 2023 period included approximately $194,000 of bad debt expense. As a public company, we expect general and administrative costs to continue to increase in future periods.
Previous wording
During the three months ended March 31, 2024, operating activities used approximately $436,000 of cash, including providing a $220,000 of financing to a film production company and payments resulting in a $42,000 reduction in accounts payable and accrued expenses.
Current wording
During the Six months ended June 30, 2024, operating activities used approximately $741,000 of cash including providing $396,000 of financing to film production companies.
Rearranged current paragraphs (7)
Current report — wording carried from elsewhere
During the three months ended June 30, 2024, operating activities used approximately $306,000 of cash, including providing $176,000 of financing to a film production company. During the three months ended June 30, 2023, operating activities consumed approximately $188,000 of cash.
Current report — wording carried from elsewhere
The following table summarizes our results of operations for the six months ended June 30, 2024 and 2023:
Current report — wording carried from elsewhere
Sales and marketing expenses for the six months ended June 30, 2024 were approximately $25,000 compared to $0 for the three months ended June 30, 2023. Sales and marketing expenses relate to our engagement of a part-time marketing consultant during the period and related expenses.
Current report — wording carried from elsewhere
*Interest Income.*Interest income for the Six months ended June 30, 2024 and 2023 was approximately $486 and $2,453, respectively, and consisted of interest earned on invested cash balances.
Current report — wording carried from elsewhere
Interest Expense. Interest expense for the Six months ended June 30, 2024 and 2023 was approximately $16,000 and $4,000, respectively, and was primarily related to ourEconomic Injury Disaster Loan (“EIDL”), commercial line of credit and related party working capital loans.
Current report — wording carried from elsewhere
During the first Six months of 2024, the Company sold 691,000 shares of Common Stock for $0.25 per share resulting in total proceeds of approximately $469,000. During the six months ended June 30, 2023, the Company sold 3,333,333 shares of Common Stock at $0.15 per share resulting in total proceeds of approximately $500,000. We had an accumulated deficit of approximately $6.9 million, incurred a net loss of approximately $1.9 million, and had cash outflows from operations of approximately $742,000 as of and for the six months ended June 30, 2024. Further, we expect to continue to incur significant costs in the pursuit of our business plans. We cannot assure you that our plans to raise capital or to complete our film development and production activities will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.
Current report — wording carried from elsewhere
Since our inception, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we develop and produce feature films. To date, we have funded our operations with proceeds from sales of Common Stock and borrowings from related parties under promissory notes. As of June 30, 2024, we had cash and cash equivalents of approximately $8,000.